Company news

Poolbeg Pharma PLC news in 2025

Poolbeg Pharma PLC's news releases, calls and decks from 2025, newest first.

View company

Letter to Shareholders – 2025 a year of progress

December 18, 2025

POLB 001 to feature in CRS research programme

December 8, 2025

POLB 001 European Patent granted

November 20, 2025

Interim Results for the six months to 30 June 2025

September 29, 2025

POLB 001 Phase 2a Trial Update

September 25, 2025

Director/PDMR Shareholding

June 25, 2025

Results of GM and AGM Meetings

June 23, 2025

FDA Orphan Drug Designation granted for POLB 001

May 27, 2025

Annual Report, AGM Notice & Circular

May 27, 2025

Result of upsized oversubscribed BookBuild Offer

May 23, 2025

Increase of BookBuild Offer

May 22, 2025

Result of Placing and Notice of General Meeting

May 20, 2025

Proposed Retail Offer to raise up to £100,000

May 20, 2025

Proposed Fundraising to raise approximately £4.1M

May 20, 2025

Results for the year ended 31 December 2024

May 20, 2025

Conference Participation in March & April 2025

March 27, 2025

POLB 001 Patent Granted in Korea

March 20, 2025

Termination of proposed combination with HOOKIPA

February 21, 2025

HOOKIPA Pharma Inc. (“HOOKIPA”) Statement reg...

February 20, 2025

Holding(s) in Company

February 18, 2025

Offer Update - Extension to PUSU Deadline

January 30, 2025

Update Potential Combination of Poolbeg & HOOKIPA

January 10, 2025

Combination of Poolbeg and HOOKIPA Pharma Inc.

January 2, 2025

Calls in 2025

Decks in 2025